Condition
Branch Atheromatous Disease
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Completed2
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07761182Not Yet RecruitingPrimary
Cognitive Outcomes in BAD-related Stroke
NCT07693816RecruitingPrimary
Early Identification and Diagnosis of BAD-related Stroke
NCT06037889Phase 3CompletedPrimary
Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)
NCT05310968Phase 4CompletedPrimary
Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction
Showing all 4 trials